Anticoagulants Flashcards

1
Q

The three basic mechanisms of hemostasis are

A

Vasoconstriction, platelets, and clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Basic steps in hemostasis

A

1) Vasoconstriction
2) Formation of platelet plug
3) Activation of clotting cascade
4) Formation of fibrin blood clot
5) Clot retraction and dissolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary hemostasis

A

Occurs immediately

Results in platelet plug

Exposed subendothelial collagen attracts platelets which start to adhere to each other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Factors involved in primary hemostais (also causes local vasoconstriction)

A

vWF
CF VIII
ADP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adhered platelets release ________ and use _____ and _____ as a connecting agent

A

TXA2

Fibrinogen and vWF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Platelet degranulation agents

A

5-HT, Histamine- vasoconstrictors

Thromboxane- vasoconstriction/degranulation

ADP- promotes adherence and degranulation

CF Va, VIIIa, IXa

Platelet factor 4 (heparin neutralizing factor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Secondary hemostasis takes place over what kind of time frame?

A

Minutes to hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the end product of the coag cascade in secondary hemostasis?

A

FIBRIN

This forms the meshwork of protein that helps to stabilize the platelet plug and trap other cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Basic intrinsic pathway (PTT)

A

Factor XIIa–> Xa–>Prothrombin–> Thrombin

Fibrinogen–> Fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Basic extrinsic pathway (PT)

A

Tissue factor and Factor VIIa–> Xa–>
Prothrombin–> Thrombin
Fibrinogen–> Fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Natural anticoagulants

A
PCI2
Antithrombin III
Heparin
Protein C
Protein S
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

After a clot forms and stabilizes, it then

A

Retracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does clot retraction work?

A

Platelets trapped in the fibrin mess contain actinomyosin-like contractile proteins, which squeeze out protein-free serum. This mostly takes place within the first hour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the fibrinolytic system

A

Mediated by plasmin,which becomes activated by coagulation and inflammation substances

Plasmin splits fibrin and fibrinogen into fibrin degradation products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Antiplatelet aggregation agents

5 oral

3 IV

A

Oral agents- aspirin, ticlopidine, clopidogrel, prasugrel, ticagrelor

IV- abciximab, eptifibatide, tirofiban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does aspirin inhibit? What type of inhibition is it?

A

COX inhibitor

Irreversible! Remember platelets are around for about 10 days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Aspirin is indicated for

A

Prevention of recurrent ischemic events, such as stroke, MI, and symptomatic PVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ASA dose

A

81-325mg qday

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ASA precautions

A

Children (Reye’s syndrome)
Pregnancy
CV- blocks ACE, BB, and diuretic effects d/t prostaglandin inhibition
Asthmatics- results in increased leukotriene production
Increased bleeding with other anticoags

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Treatment for over anti-coagulation with ASA?

A

Platelet transfusion, otherwise you gotta wait a long time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How does ticlopidine (ticlid) work?

A

Blocks APD receptor on platelets and inhibits fibrinogen binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When is ticlopidine used?

A

Same indications as ASA, usually used for ASA intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Ticlopidine is bad news bears because…

A

It causes extreme neutropenia, thrombotic thrombocytopenic purpura, GI upset (really..?), and its also teratogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Clopidogrel (Plavix) works by

A

Irreversibly blocking ADP receptor on platelet and inhibits fibrinogen binding

Used for same stuff as ASA, usually as dual therapy with ASA (more effective, also more bleeding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Clopidogrel dosing

A

Loading dose of 300mg or 600mg

Daily dose of 75mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Clopidogrel precautions

A

Metabolized by CYP2C19, may need increased dosing due to genetic variation

Inhibits CYP450

Severe renal/hepatic disease, reduce dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

For alllllll of these drugs using more than one will…

A

Increase your risk of bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Clopidogrel pts most at risk of bleeding?

A

Elderly, underweight, previous TIA/stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Bleeding treatment on clopidogrel

A

Stop drug

GIve platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Prasugrel (Effient) what is it? When might a pt be on it?

A

New thienopyridine, better risk reduction than clopidogrel, but also causes more fatal bleeding events

Often used in clopidogrel non-responders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Prasugrel dosing and precautions

A

10mg qday

Active bleeding

Previous stroke/tia, underweight, >75- consider 5mg qday

Risk of bleeding during CV surg is 4x greater than clopidogrel. Don’t use pre-cath.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Ticagrelor (Brilinta) works by ______? How does it compare to clopidogrel?

A

Blocks ADP receptors by allosteric antagonism

Better than clopidogrel for mortality reduction post MI/stroke, but also more bleeding and much higher rate of fatal ICH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Ticagrelor uses and dosing

A

Prevention of recurrent ischemic events after stroke, ACS, and post PCI

180mg once, 90mg bid thereafter

Always as dual therapy with ASA unless contraindicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Ticagrelor precautions

A

ASA more than 100mg aday

Hepatic dysfunction

Hold for >5 days pre-surg

BID dosing

Contraindications- active bleeding, ICH history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

How do GPIIb/IIIa inhibitors work? Uses? 3 drugs-

A

Block GPIIb/IIIa receptor, which prevents fibrinogen binding

Used for ACS and PCI

Abciximab (ReoPro), Eptifibatide (Integrilin), Tirofiban (Agrastat)

36
Q

Abciximab (ReoPro) is used for _______? When used with heparin what’s the aPTT goal? Downsides?

A

Used in ACS with planned PCI

aPPT goal of 60-85 sec

Most expensive in its class and most prolonged effects

37
Q

Eptifibatide uses and dosing considerations

A

Used for ACS and PCI

Dosing based on serum creatinine
<2.0 mg/dl- 2.0 mcg/kg/min for up to 72 hours
2.0-4.0 mg/dl- 1.0mcg/kg/min for up to 72 hours

38
Q

GPIIb/IIIa inhibitors- How do you treat bleeding?

A

Abciximab (ReoPro)- reverse with platelets

Eptifibatide (Integrilin) and Tirofiban- turn it off and wait

39
Q

Temporary interruption of anti-platelet therapy should take place _______ prior to surgery

A

7-10 days

40
Q

Anti-platelet therapy should resume ________ post-op as long as hemostasis is achieved

A

within 24 hours or next AM

41
Q

For pts at high risk of CV events, when should ASA/Clopidogrel be stopped?

A

ASA should NOT be discontinued

Clopidogrel should be stopped at least 5 days prior to surg

42
Q

How does heparin work and what is it used for?

A

Activates antithrombin III–> increases inhibition of thrombin IIa and Factor Xa 1000 fold

Used for DVT prophylaxis/treatment, PE treatment, ACS, when warfarin is started or contraindicated

43
Q

Heparin dosing for DVT prophylaxis

A

5000 units SubQ q8hrs (q12hr dosing sometimes…for NeuroSurg, ESRD)

44
Q

IV infusion heparin dosing

A

Weight-based bolus
Weight-based infusion

Protocol adjusted by aPTT or anti-Xa values (q6hrs until stable, then qday)

45
Q

Drawbacks of heparin

A

Variable effect, frequent titration

DOES NOT inhibit clot-bound thrombin

46
Q

Heparin reversal agent

A

Protamin 1mg/100u of heparin

47
Q

Incidence of HIT

A

1% @ 7 days

3% @ 14 days

48
Q

HIT type I

A

Non-immune mediated, BENIGN

Mild drop in platelets, <4 days, not progressive nor associated with thrombosis

49
Q

HIT type II

A

Immune mediated, more typical onset and MORE BAD

Always follows heparin exposure (check history)
Reduction in platelets to <150,000 OR 50% reduction from PRE-HEPARIN exposure

Typically 7-14 after initial exposure, but may be much shorter if pt was exposed in the past

50
Q

Thrombocytopenia occurs what percent of the time with heparin therapy? More common in UF or LMWH?

A

about 2-5

More common in UF heparin

51
Q

Typical pt/platelet count/onset time for thrombocytopenia

A

Surg>med>OB

38,000-60,000

Typical onset (66%)- exposure of 5-14 days
Delayed (3-5%)- exposure of 2-6 weeks
Rapid (25-30%) hours-days (usually has history of heparin exposure and circulating antibodies from previous 100 days)

52
Q

HITT (HIT with thromboembolism)

% of cases

Venous vs Arterial

Mortality rate and amputation rate

A

10-25% of cases

Venous (4x more common)- DVT, PE, venous limb gangrene, dural sinus thrombosis

Arterial- CVA, limb ischemia, skin necrosis, MI, gut ischemia, adrenal/renal/spinal artery infarcts

25-30% mortality, 25% amputation rate

53
Q

HIT lab tests

A

ELISA

  • measures titer of IgG to heparin-PF4 complex
  • simple and readily available
  • 90% sensitive, 80% specific

SRA

  • detects platelet activation
  • labor intensive, usually a send-out lab
54
Q

Management of HIT

A

Stop all pro-thrombocytopenic drugs

STOP heparin (FOREVER) and START non-heparin anti-coag (usually Argatroban)

Check history for heparin exposure

Remove all sources of heparin (flushes, coated devices, sq DVT prophylaxis)

55
Q

LMWH (Enoxaparin) MOA and uses

A

~5,000 daltons in size

Binds antithrombin III and inhibits factor Xa

Used for DVT prophylaxis, ACS, and VTE treatment

56
Q

How can the effects of LMWH be checked?

A

Anti-Xa levels, but this is not routinely done

57
Q

In what pt population on LMWH therapy would you want to monitor anti-Xa levels

A

Pregnant women

58
Q

Precautions with LMWH

A

Use weight based dosing for obese pts

Not recommended in severe renal insufficiency, decrease dose by 50% if no alternative

Contraindicated in spine surg and patients with epidural catheters

59
Q

Can protamine reverse LMWH?

A

Yes, but only ~60% reversal

60
Q

How does Fondaparinux (Arixtra) work? What is it used for?

A

It is a synthetic factor Xa inhibitor. Binds with anti-thrombin III to potentiate Xa inhibition (300x). No effect on IIa (thrombin).

Used in ACS, PE/DVT prophylaxis, DVT treatment

61
Q

Fondaparinux dosing, contraindications, reversal

A

7.5mg subq qday for prophylaxis, 10mg for VTE or wt >100kg

Contraindicated for CrCl< 30 ml/min, spinal puncture/anesthesia

No known reversal, FFP ineffective. Discontinue drug and provide supportive care.

62
Q

Direct thrombin (IIa) inhibitors

A

Hirudin, lepirudin, desirudin, hirulog, argatroban (reversible), bivalirudin

Used in HIT (argatroban, lepirudin)
PCI (Bivalirudin)

63
Q

Toxicities, interactions, and bleeding treatment for direct thrombin inhibitors

A

Bleeding
Lepirudin and Desirudin can only be used once on a patient d/t anaphylaxis risk

Increased bleeding with other anti-coagulants

Stop infusion, may respond to factor VII, FFP, and cryoprecipitate

64
Q

What does warfarin interfere with?

A

Production of vitamin K dependent clotting factors (II, VII, IX, X) and carboxylation of natural anticoagulants protein C and protein S

65
Q

What is warfarin used for?

A

DVT, a-fib, mechanical heart valve thrombosis prevention

Long-term VTE treatment

66
Q

The INR goal for most warfarin indications is

A
  1. 0-3.0

2. 5-3.0 in high risk pts

67
Q

For uncomplicated DVT/PE what is the normal duration of warfarin therapy?

A

3 months

68
Q

When transitioning to warfarin, how long should heparin or LMWH overlap for?

A

1-2 days

69
Q

What genetic variants can require changes in warfarin dosing?

A

Variations in CYP2C9 can decrease warfarin metabolism

Variations in vitamin k expoxide reductase can require dose reductions

70
Q

Warfarin toxicities

A

Bleeding, birth defects, cutaneous necrosis

71
Q

Warfarin interactions

A
Increased effect-
Amiodarone
CImetidine
Acetaminophen
Phenylbutazone
Decreased effect-
Sucralfate
Cholestyramine
Spironolactone
Barbiturates
Vitamin k containing foods
72
Q

Warfarin reversal

A

Vitamin K, IV or PO

FFP

73
Q

In terms of surgery, when should warfarin be stopped and restarted?

A

5 days prior to OR

Restarted 12-24 hours post-op if normal hemostasis has been achieved

High risk patients can be bridged with heparin up to 4-6hrs pre-op

74
Q

What does dabigatran (pradaxa) inhibit? What is it used for?

A

It is a direct thrombin inhibitor (IIa)

Stroke prevention in non-valvular a-fib and VTE prophylaxis after total knee/hip replacement

110mg bid for high bleeding risk or renal impairment , otherwise 150mg bid

75
Q

How does dabigatran to warfarin?

A

150mg dose is superior for reduction of stroke and systemic embolism with no difference in bleeding.

110mg dose in noninferior for prevention and has a 20% reduction in bleeding risk

76
Q

All of the new oral anticoagulants (dabigatran, rivaroxaban, and apixaban) have what disadvantages?

A

High cost (bid dosing for apixaban), no antidote, no assay for monitoring, and no long term data.

77
Q

Rivaroxaban (Xarelto) MOA, uses, and dosing

A

Direct factor Xa inhibitor

Used for stroke and systemic embolism prevention in a-fib

20mg qday

78
Q

How does rivaroxaban compare to warfarin?

A

noninferior, similar bleeding risk, but decreased risk of ICH and fatal bleeding

79
Q

Advantages of dabigatran

A

No routine monitoring needed
Less influenced by diet and other drugs
Rapid time to peak action (1 hr)
Short half like (12-14 hrs) in pts with normal renal function

80
Q

Apixaban (Eliquis) MOA, uses, dosing

A

Direct Xa inhibitor

Used for stroke and systemic embolism prevention in a-fib

5mg bid

81
Q

How does apixaban compare to other anti-coags

A

Clear benefit over ASA for patients unable to take warfarin

Superior to warfarin for prevention and reduced risk of bleeding, in particular lower rates of ICH and mortality

82
Q

Fibrinolytic drugs and how they work

A

Streptokinase, Urokinase, t-PA, Tenecteplace (TNK-ase)

Plasminogen activators convert plasminogen to plasmin–> plasmin causes fibrinolysis

83
Q

Uses for fibrinolytics

A

Acute ST-elevation MI

Acute ischemic stroke (within 6 hours of symptom onset) t-PA only

Urokinase only for PE or central line de-clotting

84
Q

tPA dosing vs TNKase dosing

A

tPA 10 units over 2 min, repeat in 30 minutes

TNKase 30-50mg given as a one time bolus over 5 seconds

85
Q

Absolute contraindications for fibrinolytics

A

Previous hemorrhagic stroke
Ischemic stroke in last 3 months or acute within last 3 hours
Known intracranial neoplasm
Active internal bleeding, excluding menses
Suspected aortic dissection
SIgnificant closed head or facial trauma within 3 months

86
Q

Relative contraindications for fibrinolytics

A

BP > 180/110, treating it is ok in terms of removing this contraindication

Severe chronic HTN

INR>2.5, use of other anticoagulants

Known bleeding disorder

Non-compressible vascular puncture

Recent trauma within 2-4 weeks (traumatic CPR)

Major surg <3 weeks

Recent internal bleeding or PUD (2-4 weeks)

Pregnancy

For streptokinase allergy or prior exposure (5 days to 2 years)